Impact of COVID-19 Pandemic on Infant Vaccination Completion Rates in the United States
Sunday, April 24, 2022
9:00 AM – 9:15 AM US MT
Location: Convention Center: 605
CE: Enduring CME: 0.25
Publication Number: 2175.5
Liping Huang, Pfizer Inc., Collegeville, PA, United States; Jennifer L Nguyen, Pfizer, New York, NY, United States; Johnna Perdrizet, Pfizer Inc, New York City, NY, United States; Tamuno Alfred, Pfizer Inc, New York, NY, United States; Adriano Arguedas, Pfizer, Collegeville, PA, United States
Presenting Author(s)
LH
Liping Huang, MD, MA, MS
Director, HEOR Vaccine Pfizer Inc. Collegeville, Pennsylvania, United States
Participants should be aware of the following financial/non-financial relationships:
Liping Huang, MD, MA, MS: ● Pfizer Inc. (Currently Ongoing) (Products/Services: Employment with an ineligible company).
Jennifer L Nguyen, ScD, MPH: ● Pfizer (Currently Ongoing) (Products/Services: Employment with an ineligible company, Ownership Interest including individual stocks, stock options, excluding diversified mutual funds).
Johnna Perdrizet, MPH: ● Pfizer Inc (Currently Ongoing) (Products/Services: Employment with an ineligible company, Ownership Interest including individual stocks, stock options, excluding diversified mutual funds).
Tamuno Alfred, PhD: ● Insmed Inc (Ended In the Past 24 Months) (Products/Services: Consultant). ● Pfizer Inc (Currently Ongoing) (Products/Services: Employment with an ineligible company).
Adriano Arguedas, n/a: ● Pfizer employee (Currently Ongoing) (Products/Services: Employment with an ineligible company).
